术前血小板计数与非心脏手术后围术期心血管事件的关联
基于美国国家外科质量改进计划2009至2015年3053308例成人非心脏手术患者,术前90天内血小板计数与术后30天主要不良心血管事件(MACE)呈U形关系;轻度和中重度血小板减少及中度和重度血小板增多均与MACE风险升高相关,死亡、心肌梗死、卒中单独终点结果一致。
要点
- 术前血小板减少与增多均与30天MACE风险升高相关,呈U形关系。
- 轻度血小板减少aOR 1.44,中重度减少aOR 2.79,中度和重度增多aOR分别为1.57和1.91。
- 死亡、心肌梗死、卒中单独终点结果与复合终点一致。
核心结论
- 在成人非心脏手术患者中,术前血小板减少和血小板增多见于近12%的病例,并与30天心血管事件 odds 升高相关。
研究设计与样本
- 从国家外科质量改进计划中识别2009至2015年接受非心脏手术的18岁及以上成人。
- 记录术前90天内血小板计数,前瞻性随访30天,主要结局为30天MACE(死亡、心肌梗死或卒中的复合终点)。
- 采用多变量logistic回归模型估计血小板计数与术后结局 odds 的关联。
主要发现
- 在3053308例手术患者中,7.5%有血小板减少(6%轻度[血小板计数100-150×10^9/L],1.5%中重度[<100×10^9/L]),4.4%有血小板增多(4%中度[400-600×10^9/L],0.4%重度[>600×10^9/L])。
- 血小板计数与MACE呈U形关系。
- 轻度血小板减少aOR 1.44(95%CI 1.39-1.48),中重度血小板减少aOR 2.79(95%CI 2.69-2.90)。
- 中度血小板增多aOR 1.57(95%CI 1.52-1.63),重度血小板增多aOR 1.91(95%CI 1.74-2.09)。
- 死亡、心肌梗死和卒中单独终点的结果与复合终点一致。
关键数值与推荐
- 血小板减少定义为血小板计数<150×10^9/L,其中轻度为100-150×10^9/L,中重度为<100×10^9/L。
- 血小板增多定义为血小板计数>400×10^9/L,其中中度为400-600×10^9/L,重度为>600×10^9/L。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Platelets are major players in the pathogenesis of cardiovascular events, and the number of circulating platelets in whole blood is routinely available in clinical testing. The relationship between the preoperative platelet count and major adverse cardiovascular events (MACE) after noncardiac surgery is uncertain. OBJECTIVES: In this paper we aim to explore the relationship between abnormal platelet counts and major adverse cardiac events (MACE) after noncardiac surgery. METHODS: We identified adults aged ≥18 years undergoing noncardiac surgery from 2009 to 2015 from the National Surgical Quality Improvement Program. Preoperative platelet counts within 90 days of surgery were recorded. Patients were prospectively followed for 30 days. The primary outcome was 30-day MACE (a composite of death, myocardial infarction, or stroke). Multivariable logistic regression models estimated the association between platelet count and the odds of postoperative outcomes. RESULTS: Among 3 053 308 surgical patients, 7.5% had thrombocytopenia (6% mild [platelet count 100-150 × 109/L] and 1.5% moderate-severe [<100 × 109/L]), and 4.4% had thrombocytosis (4% moderate [400-600 × 109/L] and 0.4% severe [>600 × 109/L]). There was a U-shaped relationship between platelet count and MACE. The adjusted odds of MACE were elevated in mild (adjusted odds ratio [aOR], 1.44; 95% CI, 1.39-1.48) and moderate-severe thrombocytopenia (aOR, 2.79; 95% CI, 2.69-2.90) and in moderate (aOR, 1.57; 95% CI, 1.52-1.63) and severe (aOR, 1.91; 95% CI, 1.74-2.09) thrombocytosis. Findings were consistent for the individual endpoints of death, myocardial infarction, and stroke. CONCLUSION: In adults undergoing noncardiac surgery, preoperative thrombocytopenia and thrombocytosis were identified in nearly 12% of cases and were associated with increased odds of cardiovascular events at 30 days.
引用
- Wilcox T, Smilowitz NR, Berger JS, et al. Association between preoperative platelet count and perioperative cardiovascular events after noncardiac surgery. J Thromb Haemost. 2025. PMID: 40268273. doi:10.1016/j.jtha.2025.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。